DK0796103T3 - Anvendelse af røgelse til behandling af Alzheimer-sygdommen - Google Patents
Anvendelse af røgelse til behandling af Alzheimer-sygdommenInfo
- Publication number
- DK0796103T3 DK0796103T3 DK95940992T DK95940992T DK0796103T3 DK 0796103 T3 DK0796103 T3 DK 0796103T3 DK 95940992 T DK95940992 T DK 95940992T DK 95940992 T DK95940992 T DK 95940992T DK 0796103 T3 DK0796103 T3 DK 0796103T3
- Authority
- DK
- Denmark
- Prior art keywords
- incense
- disease
- treat alzheimer
- derivative
- physiologically acceptable
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 4
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 abstract 1
- 241000717739 Boswellia sacra Species 0.000 abstract 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 abstract 1
- 239000004863 Frankincense Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4444288A DE4444288A1 (de) | 1994-12-13 | 1994-12-13 | Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit |
PCT/EP1995/004586 WO1996018407A1 (de) | 1994-12-13 | 1995-11-21 | Verwendung von weihrauch zur behandlung der alzheimer-krankheit |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0796103T3 true DK0796103T3 (da) | 2001-03-05 |
Family
ID=6535638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95940992T DK0796103T3 (da) | 1994-12-13 | 1995-11-21 | Anvendelse af røgelse til behandling af Alzheimer-sygdommen |
Country Status (15)
Country | Link |
---|---|
US (1) | US5720975A (cs) |
EP (1) | EP0796103B1 (cs) |
JP (1) | JPH10510276A (cs) |
CN (1) | CN1092973C (cs) |
AT (1) | ATE198550T1 (cs) |
CA (1) | CA2207437A1 (cs) |
CZ (1) | CZ288071B6 (cs) |
DE (2) | DE4444288A1 (cs) |
DK (1) | DK0796103T3 (cs) |
ES (1) | ES2153906T3 (cs) |
GR (1) | GR3035402T3 (cs) |
PL (1) | PL320687A1 (cs) |
PT (1) | PT796103E (cs) |
RU (1) | RU2184562C2 (cs) |
WO (1) | WO1996018407A1 (cs) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19531067A1 (de) * | 1995-08-23 | 1997-02-27 | Hermann P T Prof Dr Med Ammon | Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität |
US6193993B1 (en) * | 1998-03-03 | 2001-02-27 | Eisai Co., Ltd. | Suppository containing an antidementia medicament |
WO2002024173A2 (de) * | 2000-09-20 | 2002-03-28 | R.P. Scherer Gmbh & Co. Kg | Orale zubereitungsformen von extrakten aus boswellia |
WO2002066491A1 (en) * | 2001-02-15 | 2002-08-29 | Sabinsa Corporation | Water soluble boswellic acids, their preparation and use for treating imflammatory conditions |
GB0201508D0 (en) * | 2002-01-23 | 2002-03-13 | Novartis Ag | Organic compounds |
CN1304007C (zh) * | 2002-02-04 | 2007-03-14 | 中国医学科学院药物研究所 | 乙酰乳香酸在制备肿瘤转移抑制剂中的应用 |
US7645461B2 (en) * | 2003-03-18 | 2010-01-12 | Key Neurotek AG | Method of treating cerebral ischemia with hydrogenation products of frankincense extracts |
DE10331750A1 (de) * | 2003-07-14 | 2005-02-10 | Keyneurotek Ag | Verwendung der Hydrierungsprodukte von Weihrauch (Olibanum) zur Prophylaxe und/oder Behandlung von zerebraler Ischämie, Schädel/Hirntrauma und/oder Alzheimer-Krankheit |
CN100569245C (zh) * | 2005-06-02 | 2009-12-16 | 成都中医药大学 | 乳香在制备治疗痛风的药物中的用途 |
WO2010029578A2 (en) | 2008-09-15 | 2010-03-18 | Ganga Raju Gokaraju | Synergistic anti-inflammatory compositions comprising boswellia serrata extracts |
EP2408461B1 (de) | 2009-03-17 | 2016-01-27 | Ertelt, Herta | Verfahren zur extraktion von pflanzlichen harzen sowie dadurch gewonnene extraktionsprodukte und deren verwendung |
US12005094B2 (en) | 2009-07-18 | 2024-06-11 | Compton Developments Ltd. | Inhibitor of inflammatory conditions |
WO2011010080A1 (en) * | 2009-07-18 | 2011-01-27 | University College Cardiff Consultants Limited | Inhibitor of inflammatory conditions |
US10940175B2 (en) | 2009-07-18 | 2021-03-09 | Compton Developments Ltd. | Inhibitor of inflammatory conditions |
AU2011228689A1 (en) * | 2010-03-15 | 2012-09-27 | Laila Nutraceuticals | Boswellia oil, its fractions and compositions for enhancing brain function |
PH12012501787A1 (en) | 2010-03-15 | 2012-12-10 | Laila Nutraceuticals | Boswellia oil, its fractions and compositions for enhancing brain function |
JP5876052B2 (ja) | 2010-09-07 | 2016-03-02 | レジネラ ファーマ リミテッド | マスティックガムの酸性抽出物を含む組成物 |
WO2012177825A1 (en) | 2011-06-21 | 2012-12-27 | Bvw Holding Ag | Medical device comprising boswellic acid |
ITPD20120343A1 (it) * | 2012-11-13 | 2014-05-14 | Matteo Bevilacqua | Composto in particolare per la cura della depressione e dell'ansia |
CN103393740B (zh) * | 2013-07-31 | 2015-10-14 | 中国人民解放军第四军医大学 | 乳香提取物在防治心脑血管或肝肾损伤中应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089472A (en) * | 1988-01-26 | 1992-02-18 | Laboratorios Serono S.A. | Use of growth hormone releasing factor for improving mental function |
US5064823A (en) * | 1988-08-24 | 1991-11-12 | Research Triangle Institute | Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
CA1330944C (en) * | 1988-08-24 | 1994-07-26 | De-Hua Li | Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
RU2005717C1 (ru) * | 1989-02-17 | 1994-01-15 | Такеда кемикал-индастриз Лтд | Способ получения производных аралкиламинов или их кислотно-аддитивных солей |
CN1053363A (zh) * | 1990-09-11 | 1991-07-31 | 李竞 | 能预防和缓解痛经的香水 |
DE4120322A1 (de) * | 1991-06-20 | 1992-12-24 | Bayer Ag | Aminomethyl-substituierte 2,3-dihydropyrano(2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
US5280119A (en) * | 1991-11-01 | 1994-01-18 | Boron Biologicals, Inc. | Heterocyclic amine-boranes, and method of inhibiting DNA topoisomerase activity and/or combatting inflammation, hyperlipidemia, and/or neoplasia using amine-borane compounds |
DE4201903B4 (de) * | 1992-01-24 | 2004-04-15 | Hermann P.T. Prof. Dr.Med. Ammon | Pharmazeutische Verwendung von Boswelliasäuren |
CN1033331C (zh) * | 1992-11-13 | 1996-11-20 | 中国科学院长春应用化学研究所 | 聚芳醚砜/液晶高聚物分子复合材料及制备方法 |
CN1046088C (zh) * | 1992-12-19 | 1999-11-03 | 管遵信 | 一种中药美容液及其生产方法 |
CN1030373C (zh) * | 1993-03-27 | 1995-11-29 | 张会来 | 腰痹灵 |
US5494668A (en) * | 1994-07-11 | 1996-02-27 | Patwardhan; Bhushan | Method of treating musculoskeletal disease and a novel composition therefor |
-
1994
- 1994-12-13 DE DE4444288A patent/DE4444288A1/de not_active Withdrawn
-
1995
- 1995-11-21 CN CN95197353A patent/CN1092973C/zh not_active Expired - Fee Related
- 1995-11-21 DE DE59508961T patent/DE59508961D1/de not_active Expired - Fee Related
- 1995-11-21 WO PCT/EP1995/004586 patent/WO1996018407A1/de active IP Right Grant
- 1995-11-21 RU RU97112084/14A patent/RU2184562C2/ru not_active IP Right Cessation
- 1995-11-21 JP JP8518143A patent/JPH10510276A/ja not_active Ceased
- 1995-11-21 EP EP95940992A patent/EP0796103B1/de not_active Expired - Lifetime
- 1995-11-21 PT PT95940992T patent/PT796103E/pt unknown
- 1995-11-21 ES ES95940992T patent/ES2153906T3/es not_active Expired - Lifetime
- 1995-11-21 CZ CZ19971773A patent/CZ288071B6/cs not_active IP Right Cessation
- 1995-11-21 DK DK95940992T patent/DK0796103T3/da active
- 1995-11-21 CA CA002207437A patent/CA2207437A1/en not_active Abandoned
- 1995-11-21 PL PL95320687A patent/PL320687A1/xx unknown
- 1995-11-21 AT AT95940992T patent/ATE198550T1/de not_active IP Right Cessation
-
1997
- 1997-02-05 US US08/796,857 patent/US5720975A/en not_active Expired - Fee Related
-
2001
- 2001-02-12 GR GR20010400230T patent/GR3035402T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2184562C2 (ru) | 2002-07-10 |
CA2207437A1 (en) | 1996-06-20 |
CZ177397A3 (en) | 1997-11-12 |
CZ288071B6 (cs) | 2001-04-11 |
PT796103E (pt) | 2001-04-30 |
PL320687A1 (en) | 1997-10-27 |
DE59508961D1 (de) | 2001-02-15 |
WO1996018407A1 (de) | 1996-06-20 |
CN1173134A (zh) | 1998-02-11 |
EP0796103B1 (de) | 2001-01-10 |
EP0796103A1 (de) | 1997-09-24 |
GR3035402T3 (en) | 2001-05-31 |
CN1092973C (zh) | 2002-10-23 |
JPH10510276A (ja) | 1998-10-06 |
ES2153906T3 (es) | 2001-03-16 |
ATE198550T1 (de) | 2001-01-15 |
US5720975A (en) | 1998-02-24 |
DE4444288A1 (de) | 1996-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0796103T3 (da) | Anvendelse af røgelse til behandling af Alzheimer-sygdommen | |
BR0008323A (pt) | Derivado de gabapentina para a prevenção e o tratamento de dor visceral | |
ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
BR9714363A (pt) | Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas | |
ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
ATE241365T1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
DK0854709T4 (da) | Anvendelse af boswelliasyre og derivater deraf til hæmning af normal og foröget leukocytelastase- eller plasminaktivitet | |
BR0111591A (pt) | Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes | |
DE68929388D1 (de) | Aus Harn isolierte antikoagulierende Verbindung | |
DE69327328D1 (de) | Verwendund von norastemizol zur behandlung der allergischen rhinitis | |
DE69200711D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung. | |
ATE340561T1 (de) | Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen | |
CY1105545T1 (el) | Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας | |
ATE192923T1 (de) | Verwendung von boswelliasäure zur behandlung von hirntumoren | |
RU2001118854A (ru) | Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний | |
ES2145902T3 (es) | Aplicacion del riluzole en el tratamiento de las enfermedades mitocondriales. | |
ATE285773T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten | |
ATE78168T1 (de) | Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten. | |
DE69621786D1 (de) | Aminotetralinderivat zur behandlung von herzkreislauferkrankung | |
WO2004082699A3 (de) | Verwendung von weihrauch oder seinen hydrierungsprodukten zur prophylaxe und/oder behandlung von zerebraler ischämie und/oder schädel/hirntrauma | |
DK0703781T3 (da) | Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom | |
ATE147978T1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
EP0880967A3 (de) | Nephroprotektive Arzneimittel | |
DK0707477T3 (da) | Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo |